290 related articles for article (PubMed ID: 34705049)
1. 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography and Laparoscopy for Staging of Locally Advanced Gastric Cancer: A Multicenter Prospective Dutch Cohort Study (PLASTIC).
Gertsen EC; Brenkman HJF; van Hillegersberg R; van Sandick JW; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; van der Peet DL; Daams F; van Grieken NCT; Heisterkamp J; van Etten B; van den Berg JW; Pierie JP; Eker HH; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; van Laarhoven HWM; Wevers KP; Hol L; Wessels FJ; Haj Mohammad N; van der Meulen MP; Frederix GWJ; Vegt E; Siersema PD; Ruurda JP;
JAMA Surg; 2021 Dec; 156(12):e215340. PubMed ID: 34705049
[TBL] [Abstract][Full Text] [Related]
2. Impact of
de Jongh C; van der Meulen MP; Gertsen EC; Brenkman HJF; van Sandick JW; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; Wijnhoven BPL; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; Daams F; van der Peet DL; van Grieken NCT; Heisterkamp J; van Etten B; van den Berg JW; Pierie JP; Eker HH; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; Wevers KP; Hol L; Wessels FJ; Haj Mohammad N; Frederix GWJ; van Hillegersberg R; Siersema PD; Vegt E; Ruurda JP;
Ann Surg Oncol; 2024 Jun; 31(6):4005-4017. PubMed ID: 38526832
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Implementation of FDG-PET/CT and Staging Laparoscopy for Gastric Cancer in The Netherlands.
Gertsen EC; Borggreve AS; Brenkman HJF; Verhoeven RHA; Vegt E; van Hillegersberg R; Siersema PD; Ruurda JP;
Ann Surg Oncol; 2021 Apr; 28(4):2384-2393. PubMed ID: 32901312
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).
Brenkman HJF; Gertsen EC; Vegt E; van Hillegersberg R; van Berge Henegouwen MI; Gisbertz SS; Luyer MDP; Nieuwenhuijzen GAP; van Lanschot JJB; Lagarde SM; de Steur WO; Hartgrink HH; Stoot JHMB; Hulsewe KWE; Spillenaar Bilgen EJ; van Det MJ; Kouwenhoven EA; van der Peet DL; Daams F; van Sandick JW; van Grieken NCT; Heisterkamp J; van Etten B; Haveman JW; Pierie JP; Jonker F; Thijssen AY; Belt EJT; van Duijvendijk P; Wassenaar E; van Laarhoven HWM; Wessels FJ; Haj Mohammad N; van Stel HF; Frederix GWJ; Siersema PD; Ruurda JP;
BMC Cancer; 2018 Apr; 18(1):450. PubMed ID: 29678145
[TBL] [Abstract][Full Text] [Related]
5. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
6. Should 18F-FDG PET/CT Be Routinely Performed in the Clinical Staging of Locally Advanced Gastric Adenocarcinoma?
Perlaza P; Ortín J; Pagès M; Buxó E; Fernández-Esparrach G; Colletti PM; Rubello D; Mayoral M; Sánchez N; Ruiz C; Ginés A; Fuster D
Clin Nucl Med; 2018 Jun; 43(6):402-410. PubMed ID: 29485442
[TBL] [Abstract][Full Text] [Related]
7. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
8. Added value of pretreatment (18)F-FDG PET/CT for staging of advanced gastric cancer: Comparison with contrast-enhanced MDCT.
Kawanaka Y; Kitajima K; Fukushima K; Mouri M; Doi H; Oshima T; Niwa H; Kaibe N; Sasako M; Tomita T; Miwa H; Hirota S
Eur J Radiol; 2016 May; 85(5):989-95. PubMed ID: 27130061
[TBL] [Abstract][Full Text] [Related]
9. The impact of baseline
Foley KG; Coomer W; Coles B; Bradley KM
Br J Radiol; 2022 Oct; 95(1139):20220437. PubMed ID: 36129138
[TBL] [Abstract][Full Text] [Related]
10. Staging FDG PET-CT changes management in patients with gastric adenocarcinoma who are eligible for radical treatment.
Bosch KD; Chicklore S; Cook GJ; Davies AR; Kelly M; Gossage JA; Baker CR
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):759-767. PubMed ID: 31377821
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopy, computerised tomography and fluorodeoxyglucose positron emission tomography in the management of gastric and gastro-oesophageal junction cancers.
Mirza A; Galloway S
Surg Endosc; 2016 Jul; 30(7):2690-6. PubMed ID: 26487234
[TBL] [Abstract][Full Text] [Related]
12.
Zhang S; Hu Q; Chen X; Zhou N; Huang Q; Tan S; Su M; Gou H
BMJ Open; 2024 Apr; 14(4):e075680. PubMed ID: 38643004
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of FDG PET/CT for surveillance in asymptomatic gastric cancer patients after curative surgical resection.
Lee JW; Lee SM; Son MW; Lee MS
Eur J Nucl Med Mol Imaging; 2016 May; 43(5):881-888. PubMed ID: 26611426
[TBL] [Abstract][Full Text] [Related]
14. Routinely staging gastric cancer with
Findlay JM; Antonowicz S; Segaran A; El Kafsi J; Zhang A; Bradley KM; Gillies RS; Maynard ND; Middleton MR
Eur Radiol; 2019 May; 29(5):2490-2498. PubMed ID: 30643947
[TBL] [Abstract][Full Text] [Related]
15. F-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography Has High Diagnostic Value for Pelvic and Distant Staging in Patients with High-risk Penile Carcinoma.
Ottenhof SR; Djajadiningrat RS; Versleijen MWJ; Donswijk ML; van der Noort V; Brouwer OR; Graafland NM; Vegt E; Horenblas S
Eur Urol Focus; 2022 Jan; 8(1):98-104. PubMed ID: 33685842
[TBL] [Abstract][Full Text] [Related]
16. [
Metser U; Kulanthaivelu R; Salawu A; Razak A; Mak V; Li X; Langer DL; MacCrostie P; Singnurkar A
J Nucl Med; 2023 Sep; 64(9):1371-1377. PubMed ID: 37414444
[TBL] [Abstract][Full Text] [Related]
17. Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle-invasive bladder cancer: a nationwide population-based study.
Richters A; van Ginkel N; Meijer RP; Wondergem M; Schoots I; Vis AN; Kiemeney LALM; van Rhijn BWG; Witjes JA; Aben KKH; Mertens LS
BJU Int; 2023 Oct; 132(4):420-427. PubMed ID: 37246479
[TBL] [Abstract][Full Text] [Related]
18. Association of Fludeoxyglucose F 18-Labeled Positron Emission Tomography and Computed Tomography With the Detection of Oropharyngeal Cancer Recurrence.
Sivarajah S; Isaac A; Cooper T; Zhang H; Puttagunta L; Abele J; Biron V; Harris J; Seikaly H; O' Connell DA
JAMA Otolaryngol Head Neck Surg; 2018 Nov; 144(11):1037-1043. PubMed ID: 30242338
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity.
Linz C; Brands RC; Herterich T; Hartmann S; Müller-Richter U; Kübler AC; Haug L; Kertels O; Bley TA; Dierks A; Buck AK; Lapa C; Brumberg J
JAMA Netw Open; 2021 Apr; 4(4):e217083. PubMed ID: 33881529
[TBL] [Abstract][Full Text] [Related]
20. Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography.
Chen J; Cheong JH; Yun MJ; Kim J; Lim JS; Hyung WJ; Noh SH
Cancer; 2005 Jun; 103(11):2383-90. PubMed ID: 15856477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
